Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
暂无分享,去创建一个
A. Scarpa | V. Corbo | G. Tortora | C. Sette | M. Martini | S. Ugel | E. Bria | C. Carbone | G. Piro | F. De Sanctis | P. Cappello | F. Spallotta | Antonio Agostini | P. Delfino | V. Nasca | Francesco Spallotta